Biotech

All Articles

GSK's long-acting asthma drug halved assaults in period 3

.GSK's long-acting breathing problem treatment has been actually shown to cut in half the number of ...

AstraZeneca, Daiichi unload Dato-DXd's overall survival fall short

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has stopped wo...

Roivant unveils new 'vant' to advance Bayer high blood pressure med

.Matt Gline is back along with a brand new 'vant' firm, after the Roivant Sciences chief executive o...

Viridian eye illness phase 3 hits, advancing push to competing Amgen

.Viridian Rehabs' stage 3 thyroid eye disease (TED) medical test has actually struck its own key as ...

Bain introduces $3B fund permanently science providers

.With a tough performance history for recognizing diamonds in the rough, Bain Funds Lifespan Science...

Genentech's cancer cells restructure brought in 'for scientific reasons'

.The latest decision to merge Genentech's two cancer cells divisions was produced "clinical causes,"...

Tern dental GLP-1 shows 5% weight loss at 1 month at highest dosage

.Terns Pharmaceuticals' choice to lose its own liver health condition ambitions might however repay,...

Merck, Daiichi repeat early results in small tissue bronchi cancer cells with improved ADC records

.Merck &amp Co.'s long-running attempt to land a blow on little mobile bronchi cancer (SCLC) has act...

Boehringer, Bayer advancement bronchi cancer cells medications towards Astra battle

.Some clients along with non-small tissue bronchi cancer (NSCLC) have mutations in a genetics named ...

MBX tries for $136M IPO to take competitor to Ascendis right into period 3

.MBX has fleshed out programs to take in over $136 thousand coming from its IPO as the biotech looks...